TB Wiki

Login

Portal:CML in 'raw' format

Problem importing plugins
Here is some information on CML (Chronic Myelogenous Leukemia)
{{TableOfContents}}

= General Articles =
 * [[http://en.wikipedia.org/wiki/Chronic_myelogenous_leukemia|Wikipedia article]]
 * [[http://www.answers.com/topic/chronic-myelogenous-leukemia|Answers.com (Oncology Encyclopedia) article]]

= My medical treatment =
 * [[http://www.kaiserpermanente.org/|Kaiser Permanente web site]]

== Internet info ==
 * [[http://www.podcastdirectory.com/podshows/5521523|Podcast: CML: what every newly diagnosed patient needs to know]]
 * [[http://www.leukemia-lymphoma.org/attachments/National/br_1173967761.pdf| CML: A Guide for Patients and Caregivers]]






= Life Expectancy =


= Info on white blood cells =

 * [[http://bloodjournal.hematologylibrary.org/cgi/content/full/96/10/3343|The Molecular Biology of Chronic Myeloid Leukemia]]- Blood, 15 November 2000, Vol. 96, No. 10, pp. 3343-3356



= Treatments =
== Imatinib / Gleevec ==
=== Gleevec pricing / patent issues ===
The basic patent on Imatinib expires on July 4, 2015.

 * [[http://www.livemint.com/2007/08/15003521/Don8217t-abuse-patents-sci.html|Don't abuse patents]] by Brian Druker
 * http://www.usatoday.com/news/health/2006-07-10-cancer-drugs_x.htm
 * http://www.newcmldrug.com/Discuss/reply.asp?ID=24056&Reply=24056
   * basic patent expires in 2015, generic probably available then

== Nilotinib / Tasigna ==
Tasigna is "2nd generation Gleevec"
The patent on Tasignia expires in 2023.
 * http://bmartinmd.com/2009/12/tasigna-outperforms-gleevec.html

= Patient Advocacy Gropus =
 * [[http://www.lls.org/hm_lls|Leukemia and Lymphoma Society]]
 * [[http://www.cmladvocates.net/|CML Advocates Network]]

= Interesting News =
 * [[http://abcnews.go.com/GMA/InTheSpotlight/kareem-abdul-jabbar-diagnosed-chronic-myeloid-leukemia/story?id=9041088|Kareem Abdul Jabbar diagnosed with CML]]









TBWiki engine by Tim Bird